Back to Search
Start Over
Treatment of a NSCLC patient with osimertinib based on the detection of the EGFR T790M resistance mutation in cerebrospinal fluid
- Source :
- Lung Cancer. 114:111-112
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
- Subjects :
- 0301 basic medicine
Pulmonary and Respiratory Medicine
Cancer Research
Pathology
medicine.medical_specialty
business.industry
EGFR T790M
Resistance mutation
medicine.disease
03 medical and health sciences
ErbB Receptors
030104 developmental biology
0302 clinical medicine
Meningeal carcinomatosis
Cerebrospinal fluid
Text mining
Oncology
030220 oncology & carcinogenesis
Mutation (genetic algorithm)
Cancer research
Medicine
Osimertinib
business
Subjects
Details
- ISSN :
- 01695002
- Volume :
- 114
- Database :
- OpenAIRE
- Journal :
- Lung Cancer
- Accession number :
- edsair.doi...........09fa4a82780944d3085632eaa63930a9
- Full Text :
- https://doi.org/10.1016/j.lungcan.2017.10.010